Favipiravir‐induced cutaneous adverse reactions in patients infected with COVID‐19
Author:
Affiliation:
1. Bamrasnaradura Infectious Diseases Institute Department of Diseases Control Ministry of Public Health Nonthaburi Thailand
Publisher
Wiley
Subject
Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.14953
Reference7 articles.
1. Skin manifestations of COVID‐19: a worldwide review;Tan SW;J Am Acad Dermatol,2021
2. Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist
3. Department of Medical Services Thai Ministry of Public Health.[Revised 4 August 2021 for doctors and healthcare workers Guidelines for diagnosing treating and preventing hospital infections coronavirus disease 2019 (COVID‐19)] (in Thai).https://covid19.dms.go.th/backend/Content/Content_File/Covid_Health/Attach/25640804171629PM_CPG_COVID_v.17_n_20210804.pdf
4. The efficacy and safety of favipiravir in treatment of COVID‐19: a systematic review and meta‐analysis of clinical trials;Hassanipour S;Sci Rep,2021
5. Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 cases
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical Features and Outcomes of Acute versus Chronic Urticaria Triggered by COVID-19 Infection;Advances in Skin & Wound Care;2024-04
2. A case of disseminated erythematous drug eruption caused by favipiravir in a patient with COVID‐19;Journal of Cutaneous Immunology and Allergy;2023-08-07
3. Evaluation of the Relationship between Favipiravir Use Status and Telogen Effluvium in Patients Diagnosed with COVID-19;Journal of Contemporary Medicine;2023-05-31
4. COVID-19 therapy and vaccination: a clinical narrative review;Drugs in Context;2023-02-07
5. Features of Chronic Spontaneous Urticaria Induced by COVID-19;International Archives of Allergy and Immunology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3